Guttmacher
Where you live shouldn't determine whether you can get the health care you need.
But some US lawmakers want to restrict the right to travel for abortion.
As Guttmacher expert Amy Friedrich-Ka...
On June 11, 2026, The Guttmacher Institute hosted a global launch webinar introducing the Safe Abortion Calculator. The Safe Abortion Calculator is an interactive tool that supports evidence-inform...
The US Supreme Court has ruled in Louisiana v. FDA to continue allowing telehealth, mailing and pharmacy provision of mifepristone—the first drug in the most common medication abortion regimen in t...
No matter what the courts say, mifepristone is safe, effective and essential.
Kelly Baden, Guttmacher vice president for public policy, breaks down the latest updates in Louisiana v. FDA, incl...
Floriane Borel, our Senior Global Policy Associate, delivered a statement at the 59th session of the UN Commission on Population and Development.
In order to fully achieve the vision of the Inte...
The new Oscar-nominated documentary short, The Devil Is Busy, follows staff at the Feminist Center for Reproductive Liberation in Georgia, a state with a 6-week abortion ban.
Get an inside look f...
The #GlobalGagRule is back—and this time, it may do more harm than ever before.
Here’s how the expanded policy works, and why Congress must act now to stop it.
This is the US exerting control over what the rest of the world can do.
On the SRHM Podcast episode, “The Global Gag Rule Expanded: How Anti-Rights Ideology Is Governing U.S. Foreign Aid,” Elizab...
On February 3, 2026, Dr. Elizabeth Sully, Guttmacher Institute Director of International Research, spoke at a Cable Public Affairs Channel (CPAC) press conference, joining partners to urge the Cana...
New global evidence is changing how we understand and meet sexual and reproductive health (SRH) needs.
This year, we released two major bodies of research shaping global #SRH policy:
- #AddingItU...
At #ICFP2025, Guttmacher collaborated with partners from around the world to share joint #SRHR research & explore ways to uplift their work, including through two partner-led sessions featuring ou
Medication abortion—especially mifepristone—has become the target of widespread misinformation in the United States
Guttmacher’s vice president for public policy Kelly Baden debunks common myths f...
Our federal policy director Amy Friedrich-Karnik joined Senator Schumer's press conference to break down the many harms of the reconciliation bill now before the Senate.
By “defunding” Planned Par...
During #UNGA80, our Vice President for International Research, Dr. Onikepe Owolabi, spoke at Foreign Policy Magazine’s Her Power Forum.
As Dr. Owolabi explains, measuring “need” in family plann...
Guttmacher data scientist Isaac Maddow-Zimet breaks down the impact of state abortion bans, which are forcing many people in the US to cross state lines for care.
No one should have to leave thei...
Abortion bans are costing people their health, safety, and lives. No one should be forced to stand before a judge, cross a border, or risk their future just to decide what happens to their body. Th...
We recently attended the 2025 International Population Conference in Brisbane, Australia, to present the latest sexual and reproductive health research and respond to today’s pressing issues.
Her...
Guttmacher expert Chelsea Polis spoke with @CNN about the Trump administration’s plan to incinerate nearly $10 million worth of contraceptives and the impact of denying these essential supplies to ...
Learn more: https://gu.tt/3z6oQZw